PT Industri Jamu dan Farmasi Sido Muncul Tbk operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Industri Jamu dan Farmasi Sido Muncul Tbk with three other
pharmaceutical manufacturers in Asia:
Jinghua Pharmaceutical Group Co Ltd
sales of 1.35 billion Chinese Renmimbi [US$192.90 million]
of which 92%
was Medicine Industry),
Huaren Pharmaceutical Co Ltd
(1.38 billion Chinese Renmimbi [US$197.05 million]
of which 93%
was Medicine Industry), and
J B Chemicals and Pharmaceuticals Ltd
based in India
(14.14 billion Indian Rupees [US$196.02 million]
of which 100%
PT Industri Jamu dan Farmasi Sido Muncul Tbk reported sales of 2.76 trillion Indonesian Rupiahs (US$196.19 million)
December of 2018.
increase of 7.4%
versus 2017, when the company's sales were 2.57 trillion Indonesian Rupiahs.
This was the fourth straight year of sales growth at PT Industri Jamu dan Farmasi Sido Muncul Tbk.
Sales of Pharmacy saw an increase
13.2% in 2018, from
88.52 billion Indonesian Rupiahs to 100.18 billion Indonesian Rupiahs.